CTRI/2010/091/001496
Completed
Phase 3
Evaluation of efficacy and safety of two bronchodilators for the treatment of bronchial asthma: a randomized, open label, active controlled, multicentric study.
Sun Pharmaceutical Industries Ltd., Acme Plaza, Andheri Kurla Road, Andheri East, Mumbai ? 400059. Maharashtra. India.0 sites200 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sun Pharmaceutical Industries Ltd., Acme Plaza, Andheri Kurla Road, Andheri East, Mumbai ? 400059. Maharashtra. India.
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients aged between 18 and 65 years.
- •2\. Patients diagnosed with bronchial asthma.
- •3\. Patients willing to give informed consent.
Exclusion Criteria
- •1\. Pregnant, lactating women or women of childbearing age who are not using an acceptable method of birth control.
- •2\. Patients with suspected hypersensitivity and/or contraindication to the study medication or rescue medications.
- •3\. Patients suffering from lung disease other than asthma.
- •4\. Patients with history of non\-compliance to medical regimens or those patients unwilling to comply with the study protocol.
- •5\. Patients with any severe illness like liver insufficiency, active hepatitis, known infection with HIV etc.
- •6\. Patients who have been hospitalized for asthma within three month before the study.
- •7\. Patients having any musculoskeletal, cardiovascular, or neurological condition or any other condition likely to adversely affect exercise performance or measurement of lung function.
- •8\. Patients having disease like hyperthyroidism, heart disease and diabetes mellitus.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
Evaluation of the Use of Guaco Syrup for Dilation and Reduction of Inflammation in the Respiratory Tract Through Pulmonary Function Tests in Asthmatic VolunteersAsthmaC08.127.108RBR-4n26tfniversidade federal do paraná
Recruiting
Phase 2
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With AsthmaAsthmaNCT05222529Novartis Pharmaceuticals42
Completed
Phase 2
A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThalerAsthmaNCT02148120Chiesi Farmaceutici S.p.A.60
Terminated
Not Applicable
Effectiveness of Bronchodilator Nebulization With and Without Noninvasive Ventilation in COPDChronic Obstructive Pulmonary Disease (COPD)Type 2 Respiratory FailureNCT03481543National University Health System, Singapore11
Recruiting
Phase 3
Evaluation of the effect of comparing bronchodilators with corticosteroids and bronchodilators in children with bronchiolitisIRCT20220225054120N1Ilam University of Medical Sciences60